NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis
A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

NCT02545868

CompletedPhase 3

Sponsor: Hoffmann-La Roche

Conditions: Multiple Sclerosis, Relapsing-Remitting

Interventions: 23-PPV, 13-PCV Booster, Influenza Vaccine, KLH, OCR

Countries: United States, Canada

This multicenter, randomized, open-label study will evaluate the immune response to vaccines (tetanus toxoid \[TT\]-containing adsorbed vaccine, 23-valent pneumococcal polysaccharide vaccine \[23-PPV\] either unboosted or boosted with 13-valent pneumococcal conjugate vaccine \[13-PCV\], influenza vaccine, keyhole limpet hemocyanin \[KLH\]) after administration of a dose of ocrelizumab (OCR) in participants with relapsing multiple sclerosis (RMS).

Eligibility overview

Sex: ALL

Age: 18 Years to 55 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Diagnosis of RMS in accordance with the revised McDonald criteria
* Received at least one previous immunization against TT or tetanus and diphtheria (DT/Td) or tetanus, diphtheria, and acellular pertussis (DTaP/Tdap)
* Expanded Disability Status Scale (EDSS) at Screening from 0 to 5.5 points, inclusive
* For sexually active female participants of reproductive potential, use of reliable means of contraception

Exclusion Criteria:

* Contraindications for or intolerance to oral or IV corticosteroids, including IV methylprednisolone, according to the country label
* Known presence of other neurologic disorders
* Treatment with any investigational agent within 24 weeks of screening or 5 half-lives of the investigational drug, whichever is longer, or treatment with any experimental procedure for multiple sclerosis
Locations (22)
  • Cullman, Alabama, United States
  • Tucson, Arizona, United States
  • Fullerton, California, United States
  • La Jolla, California, United States
  • Miami, Florida, United States
  • Tampa, Florida, United States
  • Farmington Hills, Michigan, United States
  • Golden Valley, Minnesota, United States
  • Chesterfield, Missouri, United States
  • Las Vegas, Nevada, United States
  • Albuquerque, New Mexico, United States
  • Staten Island, New York, United States
  • Hickory, North Carolina, United States
  • Columbus, Ohio, United States
  • Westerville, Ohio, United States
  • Abington, Pennsylvania, United States
  • Cordova, Tennessee, United States
  • Round Rock, Texas, United States
  • Salt Lake City, Utah, United States
  • Seattle, Washington, United States
  • Calgary, Alberta, Canada
  • Vancouver, British Columbia, Canada